In a major Phase 3 clinical trial, lecanemab showed it could slow the decline in memory and thinking ability by 27% overall ...
An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in ...
CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...
Leqembi is an infusion therapy that targets and removes the beta-amyloid plaque that builds up in the brains of Alzheimer's ...
An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in ...
While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...
An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now caught ...
Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...